Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Driss Chaoui

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Cytometry. Part B, Clinical Cytometry|March 29, 2006
JC-1, a sensitive probe for a simultaneous detection of P-glycoprotein activity and apoptosis in leukemic cellsDriss Chaoui, Anne-Marie Faussat, Patricia Majdak, et al.
British Journal of Haematology|July 9, 2003
Comparison of flow cytometry and enzyme cytochemistry for the detection of myeloperoxydase in acute myeloid leukaemia: interests of a new positivity thresholdRégis Peffault de Latour, Ollivier Legrand, Delphine Moreau, et al.
Transfusion|April 26, 2005
Reticulated platelets: a reliable measure to reduce prophylactic platelet transfusions after intensive chemotherapyDriss Chaoui, Tahar Chakroun, Françoise Robert, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2005
MRP3, BCRP, and P-glycoprotein activities are prognostic factors in adult acute myeloid leukemiaZineb Benderra, Anne Marie Faussat, Lydia Sayada, et al.
Leukemia & Lymphoma|May 10, 2007
Mobilization of peripheral blood progenitor cells after DHAP regimen with or without rituximab: a large multicenter comparative study in patients with malignant lymphomaRégis Peffault de Latour, Driss Chaoui, Jean-Henri Bourhis, et al.
Anti-Cancer Drugs|May 31, 2008
A multicenter study of gemcitabine-containing regimen in relapsed or refractory Hodgkin's lymphoma patientsPatricia Validire, Christophe Fermé, Pauline Brice, et al.
Hematological Oncology|September 1, 2005
Ophthalmologic and intraocular non-Hodgkin's lymphoma: a large single centre study of initial characteristics, natural history, and prognostic factorsJérôme Meunier, Livia Lumbroso-Le Rouic, Anne Vincent-Salomon, et al.
British Journal of Haematology|May 10, 2005
Relevance of the criteria commonly used to diagnose myeloproliferative disorder in patients with splanchnic vein thrombosisYasmine Chait, Bertrand Condat, Dominique Cazals-Hatem, et al.
Leukemia & Lymphoma|August 23, 2006
Conjunctival low-grade non-Hodgkin's lymphoma: a large single-center study of initial characteristics, natural history and prognostic factorsJérôme Meunier, Livia Lumbroso-Le Rouïc, Rémi Dendale, et al.
British Journal of Haematology|April 4, 2018
Tandem haematopoietic stem cell transplantation for High Risk relapsed/refractory Hodgkin Lymphoma: a LYSA studyBenedicte Deau, Sandy Amorim, Aurore Perrot, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Cytometry. Part B, Clinical Cytometry|March 29, 2006
JC-1, a sensitive probe for a simultaneous detection of P-glycoprotein activity and apoptosis in leukemic cellsDriss Chaoui, Anne-Marie Faussat, Patricia Majdak, et al.
British Journal of Haematology|July 9, 2003
Comparison of flow cytometry and enzyme cytochemistry for the detection of myeloperoxydase in acute myeloid leukaemia: interests of a new positivity thresholdRégis Peffault de Latour, Ollivier Legrand, Delphine Moreau, et al.
Transfusion|April 26, 2005
Reticulated platelets: a reliable measure to reduce prophylactic platelet transfusions after intensive chemotherapyDriss Chaoui, Tahar Chakroun, Françoise Robert, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2005
MRP3, BCRP, and P-glycoprotein activities are prognostic factors in adult acute myeloid leukemiaZineb Benderra, Anne Marie Faussat, Lydia Sayada, et al.
Leukemia & Lymphoma|May 10, 2007
Mobilization of peripheral blood progenitor cells after DHAP regimen with or without rituximab: a large multicenter comparative study in patients with malignant lymphomaRégis Peffault de Latour, Driss Chaoui, Jean-Henri Bourhis, et al.
Anti-Cancer Drugs|May 31, 2008
A multicenter study of gemcitabine-containing regimen in relapsed or refractory Hodgkin's lymphoma patientsPatricia Validire, Christophe Fermé, Pauline Brice, et al.
Hematological Oncology|September 1, 2005
Ophthalmologic and intraocular non-Hodgkin's lymphoma: a large single centre study of initial characteristics, natural history, and prognostic factorsJérôme Meunier, Livia Lumbroso-Le Rouic, Anne Vincent-Salomon, et al.
British Journal of Haematology|May 10, 2005
Relevance of the criteria commonly used to diagnose myeloproliferative disorder in patients with splanchnic vein thrombosisYasmine Chait, Bertrand Condat, Dominique Cazals-Hatem, et al.
Leukemia & Lymphoma|August 23, 2006
Conjunctival low-grade non-Hodgkin's lymphoma: a large single-center study of initial characteristics, natural history and prognostic factorsJérôme Meunier, Livia Lumbroso-Le Rouïc, Rémi Dendale, et al.
British Journal of Haematology|April 4, 2018
Tandem haematopoietic stem cell transplantation for High Risk relapsed/refractory Hodgkin Lymphoma: a LYSA studyBenedicte Deau, Sandy Amorim, Aurore Perrot, et al.
Pageof 3